Search Results - "Stellamans, Karin"
-
1
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort
Published in Clinical and translational radiation oncology (01-03-2024)“…•OligoCare is a pragmatic, observational cohort within the E2-RADIatE cohort.•Health-related quality of life is a secondary endpoint of the OligoCare…”
Get full text
Journal Article -
2
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
Published in The lancet oncology (01-03-2023)“…Stereotactic body radiotherapy (SBRT) for patients with metastatic cancer, especially when characterised by a low tumour burden (ie, oligometastatic disease),…”
Get full text
Journal Article -
3
Radiotherapy-specific quality indicators at national level: How to make it happen
Published in Radiotherapy and oncology (01-01-2023)“…•The collection of quality indicators on a national level is a valuable process in steering quality improvement initiatives.•Radiotherapy specific quality…”
Get full text
Journal Article Web Resource -
4
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort
Published in Radiotherapy and oncology (01-10-2024)“…•SBRT is commonly used for the treatment of oligometastatic disease.•Few large prospective data are available regarding SBRT-realted toxicity.•The present is a…”
Get full text
Journal Article -
5
735: Patterns of care and outcome of liver SBRT: results from a multicentre national quality project
Published in Radiotherapy and oncology (01-05-2024)Get full text
Journal Article -
6
1935: Early Quality-of-Life after metastases-directed SBRT– results of the ESTRO & EORTC OligoCare cohort
Published in Radiotherapy and oncology (01-05-2024)Get full text
Journal Article -
7
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
Published in Radiotherapy and oncology (01-06-2024)“…•Optimal dose and fractionation in SBRT for oligometastatic cancer patients remain unknown.•In the first 1,099 OligoCare patients, median number of fractions…”
Get full text
Journal Article -
8
125I brachytherapy in younger prostate cancer patients: Outcomes in low- and intermediate-risk disease
Published in Strahlentherapie und Onkologie (01-09-2017)“…Purpose To evaluate local recurrence in younger men treated with low-dose-rate (LDR) 125 I brachytherapy (BT) for localized prostate cancer. Patients and…”
Get full text
Journal Article -
9
sup 125^I brachytherapy in younger prostate cancer patients: Outcomes in low- and intermediate-risk disease
Published in Strahlentherapie und Onkologie (01-09-2017)“…Purpose To evaluate local recurrence in younger men treated with low-dose-rate (LDR) 125I brachytherapy (BT) for localized prostate cancer. Patients and…”
Get full text
Journal Article -
10
SIRT of liver metastases: physiological and pathophysiological considerations
Published in European journal of nuclear medicine and molecular imaging (01-10-2012)“…Available literature on the differences in circulation and microcirculation of normal liver and liver metastases as well as in rheology of the different…”
Get full text
Journal Article -
11
Predictors of baseline cancer‐related cognitive impairment in cancer patients scheduled for a curative treatment
Published in Psycho-oncology (Chichester, England) (01-05-2017)“…Introduction Recent research in the field of cancer‐related cognitive impairments (CRCI) has shown CRCI presentation prior to treatment initiation. Some have…”
Get full text
Journal Article -
12
Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients
Published in Journal of psychosocial oncology (04-07-2019)“…Objectives: Cognitive complaints, of objective or subjective nature, may negatively impact cancer patients' quality of life (QoL). Further, the early detection…”
Get full text
Journal Article -
13
Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective study
Published in The Lancet regional health. Europe (01-09-2024)“…Although stereotactic body radiotherapy (SBRT) was progressively adopted in clinical practice in Belgium, a reimbursement request in 2011 was not granted…”
Get full text
Journal Article -
14
Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective studyResearch in context
Published in The Lancet regional health. Europe (01-09-2024)“…Background: Although stereotactic body radiotherapy (SBRT) was progressively adopted in clinical practice in Belgium, a reimbursement request in 2011 was not…”
Get full text
Journal Article -
15
Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: A case-control study
Published in Journal of geriatric oncology (01-03-2020)“…We aimed to determine the proportion of “fit” versus “vulnerable” older patients with cancer included in phase II and III oncology registration trials, as…”
Get full text
Journal Article -
16
-
17
Developing and evaluating a participatory arts programme for cancer patients and their caregivers
Published in Acta clinica belgica (English ed. Online) (01-02-2022)“…Cancer patients, survivors and caregivers often encounter severe distress, having significant consequences to wellbeing, functionality and physical health…”
Get full text
Journal Article -
18
Case report of cold-weather-induced radiation recall dermatitis after chemoradiotherapy with cisplatin
Published in Strahlentherapie und Onkologie (01-08-2014)“…Background The radiation recall reaction (RRR) is an inflammatory reaction that occurs in previously irradiated areas. The phenomenon is probably due to an…”
Get full text
Journal Article -
19
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E 2 -RADIatE OligoCare cohort
Published in Radiotherapy and oncology (31-07-2024)“…To evaluate acute toxicity at 6 months after stereotactic body radiotherapy (SBRT) in patients with oligometastatic cancer within the OligoCare cohort…”
Get full text
Journal Article -
20
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
Published in European urology focus (01-03-2021)“…Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment…”
Get full text
Journal Article